Alpha Cognition Inc. Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement
Alpha Cognition Inc. (ACOG) had Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement of $55.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes
us-gaap:PrincipalAmountOutstandingOnLoansSecuritized · last filed 2024-11-14
- 2024-09-30: Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement $55.00K.
- 2024-06-30: Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement $55.00K.
| Period end | Principal Amount Outstanding on Loans Securitized or Asset-backed Financing Arrangement |
|---|---|
| 2024-09-30 | $55.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $55.00K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |